Current status and prospects of the treatment of juvenile idiopathic arthritis / 中华实用儿科临床杂志
Chinese Journal of Applied Clinical Pediatrics
;
(24): 6-12, 2022.
Artículo
en Chino
| WPRIM
| ID: wpr-930359
ABSTRACT
Juvenile idiopathic arthritis (JIA) is a genetically heterogeneous group of connective tissue diseases that are commonly characterized by chronic joint synovial inflammation with unknown etiology in childhood.It is cu-rrently incurable and the main therapeutic goal is to achieve clinical remission.The drugs currently used to treat JIA mainly include non-steroid anti-inflammatory drugs, glucocorticoid, disease modifying antirheumatic drugs, and biological agents.In this article, recent advances in the understanding of JIA treatment and related clinical research were reviewed, in an attempt to provide prospects for the future direction of drug development and treatment concepts.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
Chinese Journal of Applied Clinical Pediatrics
Año:
2022
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS